
Introduction
The Pharmaceutical field is the origin of the technologies adopted today in the Aseptic filling, closing and inspection of beverages without any added preservatives. Are the Food and Beverage Packaging standards competing with the Pharma standards of, as an example 10 years ago ? Unfortunately, no. To feel how delayed is in terms of safety all the Food and Beverage Packaging with respect to Pharma, we’ll quote in the following part of an U.S. Food and Drug Administration Recall Press Release. Here, Hospice, Inc. the worldwide leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, announced a voluntary nationwide (US) recall of certain lots of several lifecare products due to potential for Leakage. 1000 ml (1 liter) leaking containers recalled because potentially punctured, due to a defect in a Conveyance system:
“The issue, which Hospira notified customers (…), was identified during re-inspection of a manufactured product lot in which a single puncture mark was identified going through the overwrap and primary container.
The puncture in the primary container may result in leakage that is difficult to detect.
Leakage may result in an open system, which has the potential for:
- contamination,
- compromised sterility,
- drug waste,
- spillage,
- inadequate or inconsistent solution/medication dosing,
- delay in therapy,
all of which may require medical intervention and should be reported to Hospira and/or the U.S. Food and Drug Administration (FDA). Hazardous topical exposure may occur if a hazardous drug is added to the flexible container. Hospira’s product insert packaged with LifeCare flexible intravenous containers recommends providers do not administer unless solution is clear and the container is undamaged.

Root Cause Analysis
The root cause is attributed to a defect in a Conveyance system, and corrective actions have since been implemented to prevent a reoccurrence. To date there have been no reports of adverse events associated with this issue for the impacted lots. The manufacturing issue that caused this incident has been addressed. Hospira recommends impacted customers check with their local Hospira representative or with Hospira Customer Care regarding replacement product.
Pharmaceutical Packaging Lines, however running much slower than the majority of Food and Beverage Lines, are much more critical. In the Case Study presented here, originating by the U.S. Food and Drug Administration, the liquid into the containers is meant for intravenous injection
What is affected
The affected lots (see table below) were originally distributed by Hospira to direct accounts from September 2013 through October 2014:
- Normosol®-R pH 7.4 Multiple Electrolytes Injection Type 1, USP; 1000 mL container
- Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP; 1000 mL container
- 5% Dextrose Injection, USP; 1000 mL container
- 5% Dextrose and 0.45% Sodium Chloride Injection, USP; 1000 mL container
- Lactated Ringer's and 5% Dextrose Injection, USP; 1000 mL container
- 5% Dextrose and 0.9% Sodium Chloride Injection, USP; 1000 mL container
- Lactated Ringer's Injection, USP; 1000 mL container
- Normosol®-R Multiple Electrolytes Injection Type 1, USP; 1000 mL container
- 0.9% Sodium Chloride Injection, USP; 1000 mL container
- 0.45% Sodium Chloride Injection, USP; 1000 mL container
- Sterile Water for Injection, USP; 1000 mL container
Solution
Anyone with an existing inventory of the recalled lots should stop use and distribution and quarantine the product immediately. This recall is being carried out to the medical facility/retail level (both human and veterinary). Please notify all users in your facility. If you have further distributed the recalled product please notify any accounts or additional locations which may have received the recalled product from you and instruct them if they have redistributed the product to notify their accounts, locations or facilities to the medical facility/retail level. In addition, customers should inform potential users of these products in their organizations of this notification. Hospira will be notifying its direct customers via a recall letter and will arrange for impacted product to be returned”

Links to other Case Studies:

IntroductionIn the following, we’ll introduce the study of a pattern observed worldwide in the period 2005-2014 in the operative reality of around one-hundred Electronic Inspectors sold to be operated in-the-Machine (Labeller, Filler, Capper, Closer or Seamer). …

Case Study Sampling Table always jammedIntroductionTypical problems in a Food and Beverage Bottling Line derive by missing materials like motors, Frequency Converters, detectors, etc. In the following we’ll briefly study a Case where the “material” was much more than necessary. …
Case Study The Brewery which considered the TechnicalGuarantees part of a Contract to be honoured  ROC-curve of a Fill Level inspection. Imagine to pass 1000 times a test container through one and the same Electronic Inspector equipped with a dual Fill Level Inspection: X-ray and High Frequency (or, Optic with camera). …
IntroductionPowerade® is a famous energy beverage, the first in a row of energy drinks with great success launched in the World, after 1988. In July 2002, The Coca-Cola Company® updated the bottles of the standard Powerade to a new sport-grip bottle. …
Case study 27% rejects stopping all days a Beverage Bottling Line  The rejects' accumulation table of an Electronic Inspector in a Beverage Bottling Line, as it appeared to the eyes of the Operators and Management along 6 consecutive months after the day of the Line startup. …

Case study 1 year of Production lost   In the following a case where the Machine blamed by the Bottler never functioned correctly since the first day. 18 months later, and after two different analysis made by elements acting in conditions of …

Case study Cap presence control of sensitive beverages in 2001“X” is a great dairy filling and packaging plant. Here were installed, started and commissioned two standalone Full Bottle Inspectors in a new Aseptic Line for PET-bottled dairy products. …

Case study Cap Presence control of sensitive beverages in 2010Introduction “Y” is a great dairy filling and packaging plant. Here it has been installed a standalone Full Bottle Inspector in a new Aseptic filling Line for PET-bottled dairy products. …

Case study99.5% of the non-labelled bottles sent to the Market Non labelled and flagging-labelled bottles, manually rejected at the outfeed of a Labeller Machine. Manually rather than automatically rejected by the inspection system, because of a design-error in its configuration, amount of tracking Triggers photocells and Encoders. …

Case StudyCanning Line’s Layout Relevance   IntroductionNo one of us has X-Ray's radiographic eyes. Because of this obvious reason, the cans’ content cannot be visually verified if, due to any reason, the Full Can Inspector is not active. …

Case study Electronic inspection of Pharmaceuticalsin-the-Machine-Cycle When speaking of guarantees of asepticity, Pharmaceutical Industry is since many decades what really and only retains the maximum know-how. …

IntroductionThe Pharmaceutical field is the origin of the technologies adopted today in the Aseptic filling, closing and inspection of beverages without any added preservatives. Are the Food and Beverage Packaging standards competing with the Pharma standards of, as an example 10 years ago ? …

Case HistoryGold-made electronic cardsImagine two huge cases arrived to your store today, filled with the spare parts you ordered and waited for 4-6 months. Electronic cards and other parts urgently needed to let your Machinery produce in Quality and Safety. …

The “Device”Fusing, considered the Root Cause of whatever explosion, is just one superimposed component of an extremely longer sequence of conditions before and after, greater and smaller, than the Fuzing. …
- Expensive in-the-Machine Electronic Inspectors reduced to cheap Standalone
- Sampling Table permanently jammed
- Filling Level Technical Guarantees
- The Cardboard Label Inspector
- 27 % rejects stopping all days a Bottling Line
- 1 year of production lost
- Cap presence control of sensitive beverages in 2001
- Cap presence control of sensitive beverages in 2010
- 99.5 % of the non-labelled bottles to the Market
- Canning Line's Layout relevance
- Pharma’s in-the-Machine-Cycle electronic inspection
- Leaking Pharmaceutical Containers
- Gold-made electronic cards
- SAFF-sequence Topology
- Human-factor, industrial design and nuclear disasters
- A seismic Incident